1777 logo

SYN-TECH Chem. & Pharm. Co., Ltd. Stock Price

TPEX:1777 Community·NT$3.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

1777 Share Price Performance

NT$71.10
-24.80 (-25.86%)
NT$71.10
-24.80 (-25.86%)
Price NT$71.10

1777 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet average dividend payer.

1 Risk
1 Reward

SYN-TECH Chem. & Pharm. Co., Ltd. Key Details

NT$1.3b

Revenue

NT$842.9m

Cost of Revenue

NT$448.7m

Gross Profit

NT$187.7m

Other Expenses

NT$261.0m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
5.85
34.74%
20.21%
0%
View Full Analysis

About 1777

Founded
1982
Employees
227
CEO
n/a
WebsiteView website
www.syn-tech.com.tw

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, anti-ulcerative, antihypertensive, a-blocker, vasodilator, bronchodilator, anxiolytic, tranquilizer, local anesthetic, decongestant, antispasmodic, neuroprotective, antimigraine, pharmaceutic aid/lubricant, antiglaucoma agent, hyponatremia, antidepressant, sedative, and analgesic, as well as treatment for hyperparathyroidism and urinary frequency, benign prostatic hypertrophy, and Herpes virus helicase-primase inhibitor. The company was founded in 1982 and is based in Tainan City, Taiwan.

Recent 1777 News & Updates

Recent updates

No updates